A new indication could replace the rate of bad blood cholesterol to value the risk that a person underwent a heart attack or a cerebral vascular accident (AVC).
Up to here, the blood concentration of him "bad" cholesterol (LDL or low density lipoproteins) permitted to measure the risk to endure a cardiovascular disorder.
However, two important American organisms, the American Diabetes Association and the American College of Cardiology, sustain that the cardiologists could save more life while supervising the presence of another protein: the apolipoprotein B (B) 1 apo.
The apo B is besides a large particle size or less that transports the LDL, thus allowing him to accumulate in the blood vessels.
To measure out the medicines better
The recommendations of the two organisms aim to modify the practices of diagnosis, but the therapeutic approach will stay the same.
Thus, the medicines of the family of the statins will continue to be prescribed extensively to decrease the rate of cholesterol of people to risk. The fact to target the apo B rather than cholesterol will permit an adjustment of the dosage of the statins, one indicates.
The Canadian medical authorities did not emit any similar recommendations again. But to Quebec, the Royal Victoria hospital and the hospital Laval already adopted this new approach and several hospitable establishments of the province would be equipped to measure the B. Apo
convert this post to pdf.